Featured Clinical Trial: First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer

PsycEXTRA Dataset ◽

10.1037/e403762005-006 ◽

2005 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Abstract P6-17-14: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: A multicenter, collaborative, open-label, phase II clinical trial for the SBCCSG-36 investigators

10.1158/1538-7445.sabcs18-p6-17-14 ◽

2019 ◽

Author(s):

K Inoue ◽

J Ninomiya ◽

K Okubo ◽

T Nakakuma ◽

H Yamada ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy ◽

Open Label Phase

Download Full-text

Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial

Investigational New Drugs ◽

10.1007/s10637-019-00773-9 ◽

2019 ◽

Vol 37 (3) ◽

pp. 592-593

Author(s):

Kenichi Inoue ◽

◽

Jun Ninomiya ◽

Tsuyoshi Saito ◽

Katsuhiko Okubo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

Exemestane as First-Line Therapy in Postmenopausal Women With Recurrent or Metastatic Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31819fdf9b ◽

2009 ◽

pp. 1 ◽

Author(s):

Stefan Glück

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Postmenopausal Women ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial

Investigational New Drugs ◽

10.1007/s10637-019-00755-x ◽

2019 ◽

Vol 37 (3) ◽

pp. 538-547 ◽

Author(s):

Kenichi Inoue ◽

◽

Jun Ninomiya ◽

Tsuyoshi Saito ◽

Katsuhiko Okubo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Download Full-text

S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.

10.1158/0008-5472.sabcs11-s1-1 ◽

2011 ◽

Author(s):

RS Mehta ◽

WE Barlow ◽

KS Albain ◽

T Vandenberg ◽

SR Dakhil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Trial ◽

Postmenopausal Women ◽

Metastatic Breast ◽

Phase Iii ◽

First Line Therapy ◽

Download Full-text

WITHDRAWN: Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group

10.1054/brst.2002.0469 ◽

2002 ◽

Author(s):

B. Ejlertsen ◽

I. Højris ◽

S. Hansen ◽

K. Møholt ◽

B. Kristensen ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Pilot Study ◽

Metastatic Breast ◽

Cooperative Group ◽

First Line Therapy ◽

Download Full-text

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603351 ◽

2006 ◽

Vol 95 (7) ◽

pp. 788-793 ◽

Author(s):

A Chan ◽

◽

M Martin ◽

M Untch ◽

M G Gil ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line Therapy ◽

Download Full-text

Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

10.1055/s-0041-1730221 ◽

2021 ◽

Author(s):

A Schneeweiss ◽

D Miles ◽

E Ciruelos ◽

F Puglisi ◽

T Peretz-Yablonski ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy ◽

Global Study ◽

Locally Recurrent

Download Full-text

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan

Anti-Cancer Drugs ◽

10.1097/cad.0b013e328302eb15 ◽

2008 ◽

Vol 19 (7) ◽

pp. 753-759 ◽

Author(s):

Nahomi Tokudome ◽

Yoshinori Ito ◽

Kiyohiko Hatake ◽

Masakazu Toi ◽

Muneaki Sano ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Pharmacokinetic Study ◽

Metastatic Breast ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text